<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-2VDG9OSS</identifier><date>2009</date><creator>Zakotnik, Branko</creator><relation>documents/doc/2/URN_NBN_SI_doc-2VDG9OSS_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-2VDG9OSS_001.txt</relation><format format_type="issue">1</format><format format_type="volume">13</format><format format_type="type">article</format><format format_type="extent">str. 31</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">25704921</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-2VDG9OSS</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Adverse effects</subject><subject language_type_id="eng">Antineoplastic agents</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Family practice</subject><subject language_type_id="eng">Neoplasms</subject><title>Najpogostejši zapleti sistemskega zdravljenja raka, ki jih mora prepoznati družinski zdravnik</title><title>teme iz internistične onkologije za družinske zdravnike</title></Record>